The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia
CompletedNot applicableNCT05937711
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aimed to investigate the effectiveness of posterior tibial nerve stimulation (PTNS) in reducing pain, improving quality of life, and decreasing disease severity in patients with fibromyalgia.
Study details
- Official title
- The Effect of Transcutaneous Posterior Tibial Nerve Stimulation on Pain and Quality of Life in Patients With Fibromyalgia: a Single-blind, Randomized Controlled Trial
- Conditions
- Interventions
- Other: Transcutaneous Posterior Tibial Nerve Stimulation + Duloxetine 30 MG
- Drug: Duloxetine 30 MG
- Sponsor
- Ilker Fatih Sari
- Organization
- Giresun University
- Start date
- 2020-11-02
- Primary completion
- 2022-05-23
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patients aged between 18 and 65 years, newly diagnosed according to the American Rheumatology Association 2016 revised FMS diagnostic criteria * Patients who come regularly to sessions for posterior tibial nerve stimulation. Exclusion Criteria: * History of fracture/musculoskeletal surgery in the last 3 years * Inflammatory joint disease, or neurological disease/neurological deficit with examination * Receiving medical treatment for polyneuropathy * Contraindications to PNS (pacemaker, epilepsy, diminished skin sensation in the area to be applied).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05937711